
View larger version (28K):
[in this window]
[in a new window]
|
Fig. 3. The protective effect of KGF is not dependent on a single signaling pathway. (A) HaCaT keratinocytes were rendered quiescent by serum starvation (lane 1), treated with either the MEK1/2 inhibitor U0126 (lanes 3,7,11), the PI3K inhibitor LY294002 (lanes 4,8,12), a combination of both inhibitors (lanes 5,9,13) or solvent control (lanes 2,6,10), and subsequently incubated with 10 ng/ml KGF for the time periods indicated. Whole cell lysates were analyzed for the activation of Erk1/2, Akt1/2/3, MARCKS, JNK and p38 using phospho-specific antibodies. Levels of total Erk1/2 and total Akt1/2 were determined as loading controls. As positive controls (pos., lane 14), cells were treated with EGF (20 ng/ml for 5 minutes) for activation of Erk1/2 and Akt1/2/3, UVB irradiated (40 mJ/cm2 and incubated for 45 minutes after irradiation) for activation of JNK and p38, or treated with phorbol-12-myristate-13-acetate (200 nM, 30-minute incubation) for activation of MARCKS. The results were reproduced in three independent experiments. (B) Cytoprotection assays were carried out in the absence (upper left panel) or presence of inhibitors of different signaling pathways: MEK1/2 inhibitor U0126 (10 µM, upper right panel), PI3K inhibitor LY294002 (10 µM, lower left panel), U0126 and LY294002 (10 µM each, lower right panel). Results are mean ± s.d. **P<0.01 using the Mann-Whitney U test.
|